The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH-Reference-Cited by-同舟云学术

The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH

Published:2017-11-27 Issue:1 Volume:16 Page:175-180
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Tullius B. P.¹,Athale U.²,van Ommen C. H.³,Chan A. K. C.²,Palumbo J. S.⁴,Balagtas J. M. S.⁵,

Affiliation:

1. Division of Pediatric Hematology/Oncology and BMT; Nationwide Children's Hospital; Columbus OH USA

2. Pediatrics; McMaster University and Division of Paediatric Hematology/Oncology; McMaster Children's Hospital; Hamilton Health Sciences; Hamilton ON Canada

3. Department of Pediatric Hematology; Erasmus MC Sophia Children's Hospital; Rotterdam the Netherlands

4. Division of Pediatric Hematology; University of Cincinnati; Cincinnati OH USA

5. Division of Pediatric Hematology/Oncology; Stanford University; Stanford CA USA

Funder

C17 Research Network and Childhood Cancer Foundation

Candlelighters Canada

Coast to Coast Against Cancer

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13895/fullpdf

Reference50 articles.

1. Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH;Di Nisio;J Thromb Haemost,2014

2. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH;Khorana;J Thromb Haemost,2014

3. Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH;Baglin;J Thromb Haemost,2012

4. Epidemiology of venous thrombosis in children with cancer;Piovesan;Thromb Haemost,2014

5. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase. Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) study;Mitchell;Cancer,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombin Generation Profile Using ST-Genesia after PEG-asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia;Thrombosis and Haemostasis;2024-04-29

2. Enoxaparin is safe and effective for restoring and preserving forward portal venous flow in children with end-stage liver disease;Journal of Hepatology;2023-02

3. Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma;Frontiers in Pediatrics;2022-06-30

4. Prophylaxis of Venous Thromboembolism in Children: A Systematic Review;Seminars in Thrombosis and Hemostasis;2022-06

5. Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL‐SEHOP‐PETHEMA‐2013;Journal of Thrombosis and Haemostasis;2022-06